28 research outputs found

    Andagstøvelser for Communicantere, ruotsi

    Get PDF
    Imprimatur: Stockholm 9.8.1792. Joh. Carl Morell. Reg. past. Kgl. ord. hofpr. och cons. h.t. decanus.Lehti ):(2:Tekijän esipuhe.Nimiösivulla myös kuparipiirros: Herran ehtoollinen. Kuvateksti: Förkunner Herrans död till dess han kommer. Signeeraus: E. Åkerland sc.Arkit: 1 arkintunnukseton lehti, ):(4, A-P8 Q4. - Nimiölehden kääntöpuoli tyhjä.J. S. Ekmansonilla oli kirjapaino Tukholmassa vuosina 1796-1799, joten julkaisuvuosi on jokin niistä

    Xerophilic fungi in museum repositories challenge our perception of healthy buildings and the preservation of cultural heritage

    Get PDF
    Within the last decade, fungal infestations have emerged in Danish museum repositories challenging museum staff's health and heritage preservation. The growth is unexpected, as most repositories are climate-controlled, according to the international guidelines for heritage collections. This pilot study aims to enlighten unexpected fungal growth in three climate-controlled repositories. The environmental conditions were assessed with measurements of relative humidity (RH), temperature, and material moisture content (MC), showing no evidence of elevated moisture. Morphological and molecular identification showed the growth of A. halophilicus, A. domesticus, A. magnivesiculatus and A. vitricola; four xerophilic fungi able to grow at low water activity. Except for these species, none of the detected airborne species gave rise to growth. The growth of xerophilic fungi is inexplicable but may be associated with a revision of the international environmental guidelines for heritage collections expanding the RH range. The study questions if the revision adequately prevents the risk of fungal growth to ensure heritage preservation and the occupational health of the museum staff.publishedVersio

    Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study

    Get PDF
    BACKGROUND: Little is known about current clinical practice concerning peri-operative red blood cell transfusion in neonates and small infants. Guidelines suggest transfusions based on haemoglobin thresholds ranging from 8.5 to 12 g dl-1, distinguishing between children from birth to day 7 (week 1), from day 8 to day 14 (week 2) or from day 15 (≥week 3) onwards. OBJECTIVE: To observe peri-operative red blood cell transfusion practice according to guidelines in relation to patient outcome. DESIGN: A multicentre observational study. SETTING: The NEonate-Children sTudy of Anaesthesia pRactice IN Europe (NECTARINE) trial recruited patients up to 60 weeks' postmenstrual age undergoing anaesthesia for surgical or diagnostic procedures from 165 centres in 31 European countries between March 2016 and January 2017. PATIENTS: The data included 5609 patients undergoing 6542 procedures. Inclusion criteria was a peri-operative red blood cell transfusion. MAIN OUTCOME MEASURES: The primary endpoint was the haemoglobin level triggering a transfusion for neonates in week 1, week 2 and week 3. Secondary endpoints were transfusion volumes, 'delta haemoglobin' (preprocedure - transfusion-triggering) and 30-day and 90-day morbidity and mortality. RESULTS: Peri-operative red blood cell transfusions were recorded during 447 procedures (6.9%). The median haemoglobin levels triggering a transfusion were 9.6 [IQR 8.7 to 10.9] g dl-1 for neonates in week 1, 9.6 [7.7 to 10.4] g dl-1 in week 2 and 8.0 [7.3 to 9.0] g dl-1 in week 3. The median transfusion volume was 17.1 [11.1 to 26.4] ml kg-1 with a median delta haemoglobin of 1.8 [0.0 to 3.6] g dl-1. Thirty-day morbidity was 47.8% with an overall mortality of 11.3%. CONCLUSIONS: Results indicate lower transfusion-triggering haemoglobin thresholds in clinical practice than suggested by current guidelines. The high morbidity and mortality of this NECTARINE sub-cohort calls for investigative action and evidence-based guidelines addressing peri-operative red blood cell transfusions strategies. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02350348

    Lobrede auf den Messias

    No full text
    von Christian Bastholm, Magister der Philosophie und Pastor bey der Evangelischen Gemeine in SmirnenTitelvignett

    Den jøodiske historie

    No full text
    [s.c.
    corecore